PHS
PFM Health Sciences Portfolio holdings
AUM
$1.17B
1-Year Est. Return
26.24%
1 Year Est. Return
+26.24%
AUM
$1.17B
AUM Growth
+$18.3M
(+1.6%)
Holding
82
Top Buys
| 1 | +$24.8M | |
| 2 | +$23.8M | |
| 3 | +$20.5M | |
| 4 |
Merck
MRK
|
+$19.8M |
| 5 |
Elevance Health
ELV
|
+$19.6M |
Top Sells
| 1 | +$32.7M | |
| 2 | +$31.9M | |
| 3 | +$27.5M | |
| 4 |
Molina Healthcare
MOH
|
+$25.5M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$23.6M |
Sector Composition
| 1 | Healthcare | 97.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Liquidia Corp
LQDA
$2.99B
| – | – |
0
|
|
||
77
Masimo
MASI
$7.61B
| – | – |
-94,451
|
|
||
|
78
Molina Healthcare
MOH
$7.81B
| – | – |
-85,739
|
|
||
79
Sagimet Biosciences
SGMT
$208M
| – | – |
-90,000
|
|
||
80
UnitedHealth
UNH
$300B
| – | – |
-34,623
|
|
||
81
State Street SPDR S&P Biotech ETF
XBI
$8.18B
| – | – |
0
|
|